PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
118.09%
Revenue growth above 1.5x 6203.T's 14.70%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
134.81%
Positive gross profit growth while 6203.T is negative. John Neff would see a clear operational edge over the competitor.
2047.84%
Positive EBIT growth while 6203.T is negative. John Neff might see a substantial edge in operational management.
810.34%
Positive operating income growth while 6203.T is negative. John Neff might view this as a competitive edge in operations.
929.47%
Net income growth above 1.5x 6203.T's 4.75%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
928.95%
EPS growth above 1.5x 6203.T's 4.78%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
928.95%
Diluted EPS growth above 1.5x 6203.T's 4.78%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.71%
10Y revenue/share CAGR above 1.5x 6203.T's 3.44%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
56.91%
Positive 5Y CAGR while 6203.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-35.67%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.14%
Below 50% of 6203.T's 245.98%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
87.56%
Below 50% of 6203.T's 856.37%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-9.54%
Negative 3Y CAGR while 6203.T is 13.88%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
294.34%
10Y equity/share CAGR above 1.5x 6203.T's 44.83%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
56.00%
5Y equity/share CAGR above 1.5x 6203.T's 4.50%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
14.07%
3Y equity/share CAGR above 1.5x 6203.T's 9.33%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
46.41%
AR growth well above 6203.T's 18.12%. Michael Burry fears inflated revenue or higher default risk in the near future.
-31.45%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-5.08%
Negative asset growth while 6203.T invests at 3.21%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
11.77%
BV/share growth above 1.5x 6203.T's 4.38%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-15.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-5.64%
Our R&D shrinks while 6203.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-23.73%
We cut SG&A while 6203.T invests at 3.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.